Durect Logo Durect Header


Corporate Highlights
Letter to Shareholders
Products
Business Development/Partnering Strategy
Corporate Directory
 



Executive Officers

Felix Theeuwes, D.Sc.
Chairman,
Chief Scientific Officer
and Director

James E. Brown, D.V.M.
President,
Chief Executive Officer
and Director

Thomas A. Schreck
Chief Financial Officer
and Director

Jean I. Liu
Senior Vice President
and General Counsel

Paula Mendenhall, Pharm D.
Senior Vice President
of Operations

Su IL Yum, Ph.D.
Senior Vice President,
Engineering

Tai Wah Chan, Ph.D.
Vice President,
Pharmaceutical Research
and Development

Steven C. Halladay, Ph.D.
Vice President,
Clinical and Regulatory

Jian Li
Vice President,
Finance and
Corporate Controller
Board of Directors

Felix Theeuwes, D.Sc.
Chairman,
Chief Scientific Officer
and Director

James E. Brown, D.V.M.
President,
Chief Executive Officer
and Director

Thomas A. Schreck
Chief Financial Officer
and Director

Simon X. Benito
Director

Michael D. Casey
Director

David R. Hoffmann
Director

Armand P. Neukermans, Ph.D.
Director

Jon S. Saxe
Director

Coporate Secretary

Jean I. Liu
Senior Vice President
and General Counsel
Tel: 408.777.1417
Fax: 408.777.3577
Email: jean.liu@durect.com

Additional Information

For more information
please contact:
Schond L. Greenway
Executive Director,
Investor Relations
and Strategic Planning
Tel: 408.777.1417
Fax: 408.777.3577
Email: schond.greenway@durect.com

Mailing Address:
10240 Bubb Road
Cupertino, California 95014
www.durect.com

Annual Meeting
The company’s annual meeting
of stockholders will be held at
9:00 A.M. local time June 22,
2005 at Company Headquarters

Independent Auditors

Ernst & Young LLP
1451 California Street
Palo Alto, CA 94304
Phone 650.496.1600
Fax 650.496.4660

Corporate Counsel

Heller, Ehrman, White
& McAuliffe, LLP
2800 Sand Hill Road
Menlo Park, CA 94025
Phone 650.854.4488

Transfer Agent

EquiServe Trust Company, N.A.
150 Royal Street
Canton, MA 02021
Tel: 781.575.3400

SEC Form 10-K
A copy of the Company’s annual
report to the United States
Securities and Exchange
Commission on Form 10-K is
available without charge upon
written request to:

DURECT Corporation
Attn: Investor Relations
10240 Bubb Road
Cupertino, California 95014

Trademarks

SABER™, ORADUR™, DURIN™,
TRANSDUR™, CHRONOGESIC®,
MICRODUR™ and LACTEL®
are trademarks of DURECT
Corporation. Other referenced
trademarks belong to their
respective owners.







Contact DURECT | www.durect.com ©2005 DURECT Corporation